Skip to main content
. 2017 Aug 24;8(46):80820–80825. doi: 10.18632/oncotarget.20542

Table 2. Comparison of the incidence of hypothyroidism among initially diagnosed breast cancer patients, breast benign diseases patients and patients during chemotherapy.

Groups case Age Incidence of clinical hypothyroidism Incidence of subclinical hypothyroidism Incidence of Low T3 syndrome Incidence of total hypothyroidism
Initially diagnosed BC patients 726 51.03±10.98 2.2%(16/726) 20.25% (147/726) 6.2% (45/726) 28.65% (208/726)
BBD patients 336 44.5±12.23* 2.38% (8/336) 24.4% (82/336) 5.95% (20/336) 32.74% (110/336)
during chemotherapy 153 49.03±8.50* 2.61% (4/153) 21.57% (33/153) 6.54% (10/153) 30.72% (47/153)

*p<0.05 vs. initially diagnosed breast cancer.